Is there a role for Desmopressin as an alternative to platelet transfusion prior to procedures or Radiological InterVEntions in thrombocytopenic critically ill patients (DRIVE)? Results of a randomised double-blind placebo-controlled feasibility trial

Desborough M., Laing E., Kounali D., Mora A., Hodge R., Martin S., Shah A., Parke T., Wise M., Morgan M., McKechnie S., Stanworth S., Investigators DRIVE.

Type

Conference paper

Publication Date

04/2022

Volume

197

Pages

40 - 41

Permalink